AMN Healthcare

| July 18, 2016

Sell Side analysts that cover AMN Healthcare Services Inc (NYSE:AHS) currently have an average broker rating of 1 on the stock. This average rating comes from Zacks Research compiling polled analyst ratings taken into consideration. The average rating lands on a scale between 1 and 5. A rating of 1 or 2 would represent a Buy, and a rating of 4 or 5 would indicate a Sell. A 3 rating would indicate a Hold....

| July 11, 2016

Investors usually aim to do all the necessary homework on a particular company when analyzing the stock market. This research may include tracking how professional equity analysts view the stock. Presently, Wall Street analysts have provided a consensus stock rating of 1 on shares of AMN Healthcare Services Inc (NYSE:AHS). Covering analysts will often provide Buy, Sell, or Hold recommendations based on intensive research....

MedCity News | January 14, 2020

Digital health companies have caught the eye of prominent corporate VCs. But funding rounds aside, they’ve still struggled to gain traction in a risk-averse industry. Audience members at a panel during J.P. Morgan Healthcare asked, will it take a marriage of the technology and pharmaceutical industries for them to succeed? So many companies today aren’t just life science companies or technology companies. They’re some combination of the two, said Stacy Feld, head of Johns...

MedCity News | January 13, 2020

Healthcare analytics company Arcadia raised $29.5 million in new funding. The growth capital round was led by Cigna Ventures, with participation from past investors. Burlington, Massachusetts-based Arcadia integrates with more than 40 different electronic health record companies. It aggregates and analyzes records data to help hospitals and accountable care organizations meet metrics for value-based care. The company also develops tools to identify gaps in patient care and find ways to improve o...